Serina Therapeutics Inc is a dynamic biotechnology firm dedicated to developing groundbreaking therapies for underserved medical conditions. Utilizing its proprietary polymer-based platform, the company enhances drug delivery systems to improve patient outcomes in critical areas such as oncology and neurology. With a strong pipeline of innovative product candidates aimed at addressing significant unmet healthcare needs, Serina is strategically positioned for sustainable growth. Its focus on cutting-edge technology and collaborative partnerships underscores its commitment to advancing healthcare solutions and delivering value to stakeholders.

NYSE MKT

USA

HEALTHCARE

BIOTECHNOLOGY

601 GENOME WAY, HUNTSVILLE, AL, UNITED STATES, 35806

December

$19.1 Million

-$21.8 Million

0.0

-1.87

$0.00

0.0%

0.0